In a recent press release, iMedX, Inc. (iMedX) announced that they have successfully completed the acquisition of Prevalent, Inc. (Prevalent) and Axcension, Inc. (Axcension).
Editor's Note: This article originally appeared on iMedX's website.
iMedX, Inc. (iMedX), an international leader in revenue cycle management, medical documentation, and health information solutions has successfully completed the acquisition of Prevalent, Inc. (Prevalent) and Axcension, Inc. (Axcension). Both Axcension and Prevalent are proven providers of cutting-edge healthcare analytics and revenue cycle management consulting services.
The acquisition of these organizations completes another phase of iMedX’s ongoing global strategy to enhance healthcare technology and enable unparcelled insight into operations for healthcare facilities with the ultimate goal of improving patient care while also reducing costs.
Proprietary analytics technology from Prevalent, Axcension, and iMedX has been combined to create a never before seen business intelligence solution for healthcare providers, which allows for complete transparency and understanding across multiple systems.